| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882870 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 7 Pages |
Abstract
Auto-HCT is associated with durable remission in NSM. There was no significant difference in transplant-related mortality, TTP, and PFS in patients with NSM compared with patients with SM after high-dose therapy and auto-HCT.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ryan W. Jacobs, Rima M. Saliba, Koji Sasaki, Shatha Farhan, Aristides Armas, Nina D. Shah, Qaiser Bashir, Sofia Qureshi, Gabriela Rondon, Chitra Hosing, Uday Popat, Simrit Parmar, Jatin J. Shah, Michael Wang, Donna M. Weber, Sheeba K. Thomas,